abliva - developing drugs in rare diseases - orphan drug designation
Published 3 years ago • 222 plays • Length 5:49Download video MP4
Download video MP3
Similar videos
-
3:41
abliva - drug development - mito disease
-
3:52
abliva - drug development in mito disease - world mitochondrial disease week 2022
-
3:47
abliva - a patient-centric approach to drug development - world mitochondrial disease week 2022
-
1:06:30
abliva - kol event on kl1333 in primary mitochondrial disease, may 21, 2024
-
16:02
interview: frank j. sasinowski, us consultant specializing in regulatory matters for orphan drugs
-
1:00:26
overcoming the burden of rare diseases in europe | politico
-
1:00:08
expanded access for rare diseases
-
5:17
local company develops therapies for rare diseases
-
22:26
biostock life science summit 2021 | abliva
-
2:00
rare disease drugs and market implications
-
1:01:08
orphan drug designation webinar video
-
55:50
meet the authors: orphan drug development for rare diseases
-
9:12
orphan drug development | episode 01- what is orphan drug? | rare disease | drug regulatory affairs
-
6:31
basics - part 29 - rare and orphan diseases
-
15:52
abliva’s innovative drug development programs for primary mitochondrial diseases, m. hansson
-
58:50
webinar "multiomics and biomarkers in rare diseases supporting development of orphan drugs"
-
19:07
biostock live | abliva march 9 2021
-
2:56
orphan drugs, exclusivity, and suing the fda
-
1:58
better benefits in 90 | orphan drugs
-
21:43
drug repurposing for rare diseases scientific conference - dr daniel o'connor & johnathan underhill
-
3:27
fda incentives to promote rare disease drug development